QSAM Biosciences Signs Definitive Agreement to be Acquired by Telix Pharmaceuticals
QSAMDelisted Stock | USD 4.49 0.05 1.13% |
About 50% of Qsam Biosciences' investors are presently thinking to get in. The analysis of current outlook of investing in Qsam Biosciences suggests that some traders are interested regarding Qsam Biosciences' prospects. Qsam Biosciences' investing sentiment overview a quick insight into current market opportunities from investing in Qsam Biosciences. Many technical investors use Qsam Biosciences stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Qsam Biosciences otc stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Qsam daily returns and investor perception about the current price of Qsam Biosciences as well as its diversification or hedging effects on your existing portfolios.
Qsam |
Austin, TX, Feb. 07, 2024 -- QSAM Biosciences Inc. has signed a definitive Agreement and Plan of Merger providing for the acquisition of the Company by Telix Pharmaceuticals Limited . Pursuant to the Agreement, QSAM stockholders will receive 33.1 million in Telix ordinary shares or cash, less an adjustment amount equal to QSAMs indebtedness and payables as of the merger closing t
Read at finance.yahoo.com
Qsam Biosciences Fundamental Analysis
We analyze Qsam Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Qsam Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Qsam Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Book
Price To Book Comparative Analysis
Qsam Biosciences is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Qsam Biosciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Qsam Biosciences otc stock to make a market-neutral strategy. Peer analysis of Qsam Biosciences could also be used in its relative valuation, which is a method of valuing Qsam Biosciences by comparing valuation metrics with similar companies.
Peers
Qsam Biosciences Related Equities
LCTX | Lineage Cell | 5.00 | ||||
CVKD | Cadrenal Therapeutics, | 3.89 | ||||
APVO | Aptevo Therapeutics | 1.83 | ||||
ACHL | Achilles Therapeutics | 0.89 | ||||
ICCC | ImmuCell | 0.74 | ||||
ENLV | Enlivex Therapeutics | 0.90 | ||||
PMVP | Pmv Pharmaceuticals | 1.39 | ||||
DMAC | DiaMedica Therapeutics | 1.54 | ||||
FBIOP | Fortress Biotech | 1.68 | ||||
ASMB | Assembly Biosciences | 2.91 | ||||
CTMX | CytomX Therapeutics | 3.41 | ||||
NUVB | Nuvation Bio | 3.75 | ||||
MRKR | Marker Therapeutics | 4.17 | ||||
ONTTF | Oxford Nanopore | 5.49 | ||||
SNPX | Synaptogenix | 6.16 |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in nation. Note that the Qsam Biosciences information on this page should be used as a complementary analysis to other Qsam Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Consideration for investing in Qsam OTC Stock
If you are still planning to invest in Qsam Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Qsam Biosciences' history and understand the potential risks before investing.
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Transaction History View history of all your transactions and understand their impact on performance | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |